Adicet Bio ACET
NASDAQ ACET
$4.28 -0.21 (-4.68%)
At close: Oct 22, 2026 · 4:00 PM EDT

Adicet Bio (ACET) Current Leases (2025 - 2026)

Updated

Adicet Bio's Current Leases came in at $172,000 for Q2 2026, up 31.3% from the prior quarter.

Analysis

Adicet Bio (ACET) Current Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, Adicet Bio's Current Leases was $349,000.

  • The five-year range for quarterly Current Leases is $131,000 (Q1 2026) to $349,000 (Q4 2025).
  • Business Quant data shows ACET's Current Leases at $131,000 (Q1 2026), $349,000 (Q4 2025) and $340,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Adicet Bio 40.07 Mn -477.34 Mn - 172,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 172,000.00
Mar 31, 2026 131,000.00
Dec 31, 2025 349,000.00
Sep 30, 2025 340,000.00
API Access

Adicet Bio Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ACET&period=max&api_key=YOUR_API_KEY